Bavarian Nordic Receives Health Canada Approval of IMVAMUNE Smallpox Vaccine
Bavarian Nordic Receives Health Canada Approval of IMVAMUNE Smallpox Vaccine (Thomson Reuters ONE via COMTEX) -- KVISTGAARD, Denmark, November 22, 2013 - Bavarian Nordic A/S (omx:BAVA) BVNRY 0.00%...
SANOFI PASTEUR COMMENDS GAVI ALLIANCE FOR SUPPORTING THE INTRODUCTION OF INACTIVATED POLIO VACCINE IN WORLD'S POOREST COUNTRIES
SANOFI PASTEUR COMMENDS GAVI ALLIANCE FOR SUPPORTING THE INTRODUCTION OF INACTIVATED POLIO VACCINE IN WORLD'S POOREST COUNTRIES - Sanofi Vaccines division well positioned to contribute to further...
GAVI Alliance to support introduction of inactivated polio vaccine in world's 73 poorest countries
GAVI Alliance to support introduction of inactivated polio vaccine in world's 73 poorest countries Alliance Board selects additional vaccines to include in its portfolio Phnom Penh, 22 November...
FDA approves first adjuvanted vaccine for prevention of H5N1 avian influenza
FDA NEWS RELEASE: FDA approves first adjuvanted vaccine for prevention of H5N1 avian influenza Vaccine to supplement National Stockpile, not intended for commercial availability For Immediate...
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial No vaccine exists for the MERS virus that has killed 42% of those infected BLUE...
Bavarian Nordic Completes Delivery of 20 Million Doses of IMVAMUNE® Smallpox Vaccine to the U.S. Strategic National Stockpile
Bavarian Nordic Completes Delivery of 20 Million Doses of IMVAMUNE® Smallpox Vaccine to the U.S. Strategic National Stockpile Order completion results from a successful collaboration between...
Genocea Biosciences Appoints Katrine Bosley As Chairman Of The Board Of Directors; Vaccine Industry Leader George Siber, M.D. To Serve As Executive Director And Head Of Scientific Advisory Board
Genocea Biosciences Appoints Katrine Bosley As Chairman Of The Board Of Directors; Vaccine Industry Leader George Siber, M.D. To Serve As Executive Director And Head Of Scientific Advisory Board...
Novartis announces positive clinical trial results for novel H7N9 vaccine
Novartis announces positive clinical trial results for novel H7N9 vaccine 85% of subjects immunologically protected after receiving second dose of investigational cell culture vaccine when combined...
Researchers suggest China consider national flu vaccination plan with staggered timing
Researchers suggest China consider national flu vaccination plan with staggered timing China should tailor its influenza vaccination strategies to account for its three distinct flu regions,...
New malaria vaccines roadmap targets next generation products by 2030
New malaria vaccines roadmap targets next generation products by 2030 Partners agree approach for developing vaccines capable of reducing malaria cases by 75% and to enable malaria elimination....
Oncothyreon Announces Presentation of Data from Phase 1Trial of ONT-10
Oncothyreon Announces Presentation of Data from Phase 1Trial of ONT-10 SEATTLE, Nov. 8, 2013 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced the presentation of preliminary results...
Lumidigm Fingerprint Sensors Help Track Vaccination Histories of Children in Developing Countries
Lumidigm Fingerprint Sensors Help Track Vaccination Histories of Children in Developing Countries Biometric vaccine records are now in place for tens of thousands of adults and children in Kenya,...
Novavax Reports Third-Quarter 2013 Financial Results
Novavax Reports Third-Quarter 2013 Financial Results ROCKVILLE, Md., Nov 07, 2013 (GLOBE NEWSWIRE via COMTEX) -- Novavax, Inc. NVAX +9.97% , a clinical-stage biopharmaceutical company focused on...
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu November 13, 2013
Data are industry's first from clinical trial...
Dendreon Announces Third Quarter 2013 Results
November 12, 2013 Dendreon Announces Third Quarter 2013 Results — Implements Restructuring and Cost Reduction Plan Projected to Generate More Than $125 Million in Annual Savings — —...
Novartis announces divestiture of its blood transfusion diagnostics unit to Grifols
Novartis announces divestiture of its blood transfusion diagnostics unit to Grifols Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit for USD 1.675 billion Divestiture...
NIH launches trial of investigational genital herpes vaccine
NIH launches trial of investigational genital herpes vaccine Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The...
Agenus' HerpV Therapeutic Vaccine for Genital Herpes Meets Primary Endpoint in Randomized Phase 2 Trial
Agenus' HerpV Therapeutic Vaccine for Genital Herpes Meets Primary Endpoint in Randomized Phase 2 Trial Subjects treated with the initial three injections of HerpV showed a statistically...
AIMM Therapeutics' Pre-fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development
November 04, 2013: AIMM Therapeutics' Pre-fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development Data Showing Potent Immune Stimulating Response Published in Science AMSTERDAM...
Soligenix Submits NIAID Contract Proposal for Development of a Thermostable Ricin Vaccine
Soligenix Submits NIAID Contract Proposal for Development of a Thermostable Ricin Vaccine PRINCETON, N.J., Oct. 31, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a...
